Medinet Co (TSE:2370) Change In Receivables: 円0.0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:2370 Medinet Co Ltd TSE:2370
40 GF Score
Price 円24.00
GF Value 円41.63
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Medinet Co Change In Receivables?

Medinet Co TSE:2370 40 Change In Receivables is 円0.0 Mil as of Mar. 2026. GuruFocus rates TSE:2370 with a GF Score™ of 40/100 and a GF Value™ of 円41.63 (Possible Value Trap). The stock has 6 warning signs investors should review.

Medinet Co's change in receivables for the quarter that ended in Mar. 2026 was 円0.0 Mil. It means Medinet Co's Accounts Receivable stayed the same from Dec. 2025 to Mar. 2026 .

Medinet Co's change in receivables for the fiscal year that ended in Sep. 2025 was 円-26.9 Mil. It means Medinet Co's Accounts Receivable increased by 円26.9 Mil from Sep. 2024 to Sep. 2025 .

Medinet Co's Accounts Receivable for the quarter that ended in Mar. 2026 was 円335.7 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Medinet Co's Days Sales Outstanding for the three months ended in Mar. 2026 was 131.53.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Medinet Co's liquidation value for the three months ended in Mar. 2026 was 円2,807.8 Mil.

Medinet Co  (TSE:2370) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Medinet Co's Days Sales Outstanding for the quarter that ended in Mar. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=335.678/232.883*91
=131.53

2. In Ben Graham's calculation of liquidation value, Medinet Co's accounts receivable are only considered to be worth 75% of book value:

Medinet Co's liquidation value for the quarter that ended in Mar. 2026 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=2928.146-412.884+0.75 * 335.678+0.5 * 81.584
=2,807.8

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medinet Co Change In Receivables Related Terms

Medinet Co Change In Receivables Historical Data

* Premium members only.

The historical data trend for Medinet Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medinet Co Change In Receivables Chart

Medinet Co Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.98 48.35 -46.63 -10.18 -26.95

Medinet Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:2370
40GF Score
Medinet Co Ltd TSE:2370
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medinet Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of 円0.0 Mil mean?
Medinet Co (TSE:2370) has a Change In Receivables of 円0.0 Mil as of Mar. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Medinet Co and its competitors.
Is Medinet Co's Change In Receivables too high?
Medinet Co's current Change In Receivables is 円0.0 Mil. Overall, Medinet Co has a GF Score™ of 40/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Medinet Co's Change In Receivables compare to VRTX and REGN?
Medinet Co's Change In Receivables of 円0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Biotechnology company?
A good Change In Receivables depends on the Biotechnology industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Medinet Co and its competitors. Medinet Co's current Change In Receivables is 円0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medinet Co stock overvalued right now?
Based on GuruFocus' analysis, Medinet Co (TSE:2370) is currently considered Possible Value Trap. The stock's GF Value™ is 円41.63, compared to a current price of 円24.00 — trading 42.3% below its estimated fair value. The current Change In Receivables is 円0.0 Mil. Medinet Co's overall GF Score™ is 40/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Medinet Co (TSE:2370), the current Change In Receivables is 円0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medinet Co (TSE:2370) Overvalued in 2026?

Based on GuruFocus' analysis, Medinet Co stock appears to be undervalued. The current stock price of 円24.00 is trading 42.3% below its estimated GF Value™ of 円41.63. GuruFocus considers Medinet Co to be Possible Value Trap.

Key valuation signals for TSE:2370:

  • Change In Receivables: 円0.0 Mil
  • GF Value™: 円41.63 vs. price of 円24.00 (42.3% below fair value)
  • GF Score™: 40/100 with 6 warning signs

No single metric tells the full story. See the TSE:2370 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medinet Co Business Description

Address 1-1 Heiwajima 6-chome, 9th Floor, TRC Center Building, Ota-ku, Yokohama, JPN, 143-0006
Medinet Co Ltd is a Japan-based Contract Development and Manufacturing Organization (CDMO). The company is engaged in the research and development of regenerative medical products, investigational products, and specified cell products. MEDINET is a one-stop regenerative medicine and cell therapy solution provider. It provides value chain solutions including personnel training, facility and equipment design, facility operations and management, preparation of standard operating procedures, logistics network, information system, purchasing and production management, quality management solutions to medical institutions, research institutions, and biopharmaceutical companies.
40GF Score

Get the complete analysis for TSE:2370

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円24.00
Price
円41.63
GF Value